W H Frishman, C D Furberg, W T Friedewald. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Adrenergic beta-Antagonists/administration & dosageAdrenergic beta-Antagonists/adverse effectsAdrenergic beta-Antagonists/therapeutic useAgedAlprenolol/therapeutic useArrhythmias, Cardiac/drug therapyClinical Trials as TopicCoronary Disease/drug therapyFollow-Up StudiesHumansMyocardial Infarction/complicationsMyocardial Infarction/drug therapyMyocardial Infarction/mortalityOxprenolol/therapeutic usePindolol/therapeutic usePractolol/therapeutic usePropranolol/therapeutic useSotalol/therapeutic useTime FactorsTimolol/therapeutic use
Substances: See more » Adrenergic beta-AntagonistsOxprenololTimololAlprenololPropranololSotalolPindololPractolol
Year: 1984 PMID: 6142420 DOI: 10.1056/NEJM198403293101306
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245